查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蛋白質體學市場，到 2030 年的預測：按產品、服務和軟體、技術、應用、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1372045

全球蛋白質體學市場，到 2030 年的預測：按產品、服務和軟體、技術、應用、最終用戶和地區進行的全球分析

Proteomics Market Forecasts to 2030 - Global Analysis By Product, Services & Software,Technology, Application, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球蛋白質體學市場規模為 522.8 億美元，預計到 2030 年將達到 1,155.7 億美元，預測期內年複合成長率為 12.0%。

生物技術的領域稱為蛋白質組學，它使用分子生物學、生物化學和遺傳學技術來檢查特定細胞、組織和生物體產生的蛋白質的結構、功能和相互作用，並將資訊編譯到資料庫中。它被定義為組織並應用資料。蛋白質體學可以分為各種子類別，例如結構蛋白質體學、功能蛋白質體學和表達蛋白質體學。蛋白質體學能夠鑑定越來越多的蛋白質。這隨著時間、具體要求或細胞或生物體所承受的壓力而改變。

據 Globocan 稱，2020 年 12 月，全球報告了 1,930 萬新癌症病例和 1,000 萬癌症相關死亡。同樣，CVD也是全世界死亡的主要原因之一。例如，根據世界衛生組織（2021）的數據，年度有 4,100 萬名患者死於目標疾病。

奈米蛋白質體學的使用增加和慢性病的增加

許多蛋白質體學應用都與奈米技術相關，包括磷酸化蛋白質體學/金屬氧化物奈米粒子、用於蛋白質分離的奈米結構表面以及用於生物標記和蛋白質分析檢測的陣列技術。由於蛋白質體學技術應用於奈米技術，奈米蛋白質體學已成為研究領域。透過奈米多孔結構、功能化奈米粒子、量子點和聚合物奈米結構等眾多奈米技術應用，此技術被用作徹底改變蛋白質體學的輔助手段。因此，對個體化治療的需求以及危及生命的疾病的流行預計將使該行業在預測期內受益。

設備和試劑高成本

上市公司使用公開的結構資料和試驗技術來獲得刺激或抑制目標蛋白質的物質。蛋白質結構的研究需要使用高通量設備。使用 X光結晶的蛋白質組學經常涉及基因克隆、蛋白質表現、蛋白質精製和蛋白質結晶。所有這些過程都需要大量的實驗室時間，這提高了每個樣品的測試價格。此外，由於設備和消耗品成本高昂，開發中國家難以進入蛋白質體學領域。預計這些因素將阻礙市場擴張。

蛋白質體學的技術進步

這些技術顯著提高靈敏度和解析度，實現高通量和多重分析，促進資料整合，改進樣品製備和分級分離技術，實現基於質譜的成像，並提供先進的資料分析和資訊學工具。進步徹底改變了蛋白質體學領域。這些技術開拓使人們能夠全面徹底地了解蛋白質組，對於推動市場擴張至關重要。此外，這些技術的發展正在擴大蛋白質體學研究的範圍，使人們能夠對各種生物環境中的蛋白質進行徹底而詳細的研究，從而刺激市場擴張。

技術複雜且缺乏標準化

蛋白質體學市場的成長可能會受到技術複雜性、資料分析困難和標準化問題的阻礙。蛋白質體學研究中使用的複雜技術和方法需要專門的知識和技能。蛋白質體學資料分析和結果解釋很困難，需要生物資訊學和資料分析的專業知識。分析和解釋從蛋白質體學實驗中獲得的大量資料可能很困難。此外，由於缺乏標準化實踐以及需要強大的資料分析管道，市場擴張可能會遇到困難和障礙。

COVID-19 的影響

蛋白質體學服務受益於 COVID-19大流行，市場成長正在加速。我們觀察到，與先前的支出相比，許多公司減少了臨床試驗的研發支出，這顯示了疫情影響的嚴重性。此外，新的臨床試驗技術和模型的興起，例如 CRO 使用技術先進的質譜儀來獲得高品質的結果，導致了快速臨床試驗的報告。由於這些特點，蛋白質體學產業擁有強大的發展機會。

藥物研發領域預計在預測期內規模最大

據估計，藥物研發領域在預測期內是最大的。該行業的擴張得益於基於結構的藥物設計的進步、對個體化藥物開發的重視以及這些領域資金籌措的增加。此外，蛋白質體學技術還提供了一種在藥物研發過程階段展示藥物潛力的機制，為製藥公司節省了大量資金，並最終幫助患者和醫療保健系統，這支持了該領域的擴展。

在預測期內，光譜學領域預計將出現最高的年複合成長率。

預計光譜領域在預測期內年複合成長率最高。蛋白質體學研究主要依賴光譜學，光譜學也常用於分析蛋白質及其結構特性。這使得蛋白質能夠被識別、檢測和表徵，提供有關它們的作用、相互作用和變化的重要細節。此外，光譜技術和資料分析工具的不斷進步進一步擴大了光譜學在蛋白質組學市場中的能力和應用。

比最大的地區

預計亞太地區在預測期內將佔據最大佔有率。該地區蛋白質組學行業的擴張得益於該地區製藥公司的存在以及中國和印度等國家老年人口的不斷成長。此外，隨著個人化醫療需求的增加，對藥物研發的需求也在增加，而生物技術產業新興市場的開拓正在刺激該地區的市場擴張。亞太地區擁有最大的製藥業，並且擁有豐富的技術先進的醫療設備，蛋白質體學產品的生產商可以輕鬆獲得這些設備。

複合年複合成長率最高的地區

北美在整個主導時期排名最高，因為它專注於基於結構的藥物設計的開發、組學研究的發展、對資料可重複性的高品質研究工具的渴望以及個體化治療方法的開發。顯示出年複合成長率。該地區重要公司之間的聯盟與合作也促進了該行業的擴張。此外，為了加速複雜治療性蛋白質的特性和品質監測，Thermo Fisher Scientific Inc. 和 Symphogen 開發了經過驗證的平台流程。

免費客製化服務

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究來源
    • 主要研究來源
    • 二次研究來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球蛋白質體市場：依產品

  • 試劑/消耗品
  • 裝置
  • 服務

第6章 全球蛋白質體市場：依服務和軟體分類

  • 核心蛋白質體學服務
    • 蛋白質表徵服務
    • 蛋白質鑑定服務
    • 蛋白質精製服務
    • 定量蛋白質體學服務
    • 蛋白質序列測定服務
    • 蛋白質分離服務
    • 客製化驗服務
  • 生物資訊服務和軟體
    • 生物資訊學工具
    • 生物資訊服務
    • 生物資訊資料庫

第7章 全球蛋白質體學市場：依技術分類

  • 光譜學
    • 質譜
  • 核磁共振波譜
    • 圓二色光譜
  • 色譜法
    • 高效液相層析
    • 超臨界流體層析
    • 親和層析
    • 離子色譜法
  • 電泳
    • 凝膠電泳
    • 毛細管電泳
  • 蛋白質微陣列
    • 生物晶片
      • 晶片實驗室
      • 蛋白質晶片
    • 微陣列裝置
      • 整合系統
      • 陣列器
      • 微陣列掃描儀
  • X光結晶結構分析
  • 表面等離子體共振
  • 蛋白質分級分離
  • 其他技術

第8章 全球蛋白質體學市場：依應用分類

  • 臨床診斷
    • 感染疾病
    • 癌症
    • 糖尿病
    • 自體免疫疾病
    • 神經系統疾病
    • 心血管疾病
    • 其他臨床診斷應用
  • 臨床研究
  • 藥物研發
    • 目標發現
    • 潛在客戶最佳化
    • 線索識別
    • 臨床前研究
  • 其他用途

第9章 全球蛋白質體學市場：依最終用戶分類

  • 實驗室
  • 學術/研究機構
  • 醫院
  • 製藥公司/生物製藥公司
  • 其他最終用戶

第10章 全球蛋白質體市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章公司簡介

  • Agilent Technologies, inc.
  • Illumina, Inc.
  • Ge Healthcare
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Thermo fisher Scientific, Inc.
  • Promega Corporation
  • F. Hoffmann-La Roche Ltd.
  • Danaher
  • Merck Kgaa.
  • Waters Corporation
  • Caprion Proteomics Inc.
  • Luminex Corporation
  • PerkinElmer, Inc.
  • SomaLogic Operating Co.
  • Olink
Product Code: SMRC24101

According to Stratistics MRC, the Global Proteomics Market is accounted for $52.28 billion in 2023 and is expected to reach $115.57 billion by 2030 growing at a CAGR of 12.0% during the forecast period. The branch of biotechnology known as proteomics is defined as the application of molecular biology, biochemistry, and genetics techniques to the examination of the structure, function, and interactions of the proteins made by a specific cell, tissue, or organism, the organization of the information in databases, and the applications of the data. Proteomics can be categorized into a number of different subcategories, including structural, functional, and expression proteomics. Proteomics enables the identification of ever-increasing numbers of proteins. This varies with time and distinct requirements, or stresses, that a cell or organism undergoes.

According to Globocan, in December 2020, there were 19.3 million new cases of cancer across the world and 10 million cancer-related deaths were reported. Similarly, CVDs are one of the major causes of death worldwide. For instance, as per the WHO (2021), target diseases kill 41 million patients per year.

Market Dynamics:

Driver:

Rising use of nano proteomics and increasing prevalence of chronic illnesses

Many proteomics applications have been linked to nanotechnology, including phosphoproteomics/metal oxide nanoparticles, nanostructured surfaces for protein separation, and array techniques for analytical detection of biomarker proteins. Nanoproteomics has emerged as a field of study as a result of the application of proteomics techniques to nanotechnology. Through numerous nanotechnology applications, including nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures, this technique is used as a supporting element to revolutionize proteomics. Thus, the need for personalized therapies, along with the prevalence of life-threatening diseases, is anticipated to benefit the industry throughout the forecast period.

Restraint:

High cost of instruments and reagents

Companies obtain substances that either stimulate or inhibit target proteins using publicly available structural data and trial-and-error techniques. The study of protein structure necessitates the use of high-throughput equipment. Gene cloning, protein expression, protein purification, and protein crystallization are all frequently done in proteomics using X-ray crystallography. These processes all require a significant amount of laboratory time, which drives up the price of testing each sample. Moreover, developing nations struggle to enter the proteomics field due to the high cost of equipment and supplies. Such factors are anticipated to impede market expansion.

Opportunity:

Technological Progress in Proteomics

Technological advances that have greatly increased sensitivity and resolution, permitted high-throughput and multiplexed analysis, facilitated data integration, improved sample preparation and fractionation techniques, permitted mass spectrometry-based imaging, and provided sophisticated data analysis and informatics tools have revolutionized the field of proteomics. By enabling a complete and thorough understanding of the proteome, these developments have been crucial in fostering the market's expansion. Additionally, these technological developments have increased the scope of proteomics research, allowing thorough and in-depth investigation of proteins in a variety of biological contexts, which is fueling market expansion.

Threat:

Technological complexities and lack of standardization

Proteomics market growth may be hampered by technological complexity, data analysis difficulties, and standardization issues. Complex technologies and methodologies used in proteomics research call for specialized knowledge and skills. Proteomic data analysis and result interpretation can be difficult and require expertise in bioinformatics and data analysis. The analysis and interpretation of the enormous amounts of data produced by proteomics experiments can be challenging. Additionally, there may be difficulties and barriers to the market's expansion due to a lack of standardization practices and the requirement for strong data analysis pipelines.

COVID-19 Impact:

The proteomics services have shown to benefit from the COVID-19 pandemic, which has accelerated market growth. A number of businesses were observed to reduce their R&D expenditures for clinical trials in contrast to earlier expenditures, indicating the extent of the pandemic's impact. Additionally, due to the rise of novel clinical trial methodologies or models, which include the use of technologically advanced mass spectrometers by CROs specifically for quality outcomes, rapid clinical trials have been reported. The proteomics industry has strong development opportunities as an outcome of these traits.

The drug discovery segment is expected to be the largest during the forecast period

The drug discovery segment is estimated to be the largest during the extrapolated period. The expansion of this industry can be attributed to the development of structure-based drug design, a greater focus on developing personalized medicines, and increased funding in these fields. Additionally, proteomics technologies also provide a mechanism to demonstrate a medicine's potential early in the drug discovery process, saving pharmaceutical companies a large sum of money and ultimately assisting patients and healthcare systems, which support the segment's expansion.

The Spectroscopy segment is expected to have the highest CAGR during the forecast period

Spectroscopy segment is anticipated to have highest CAGR during the projected period. Proteomics research relies primarily on spectroscopy, which is also commonly used for analyzing proteins and their structural properties. It makes it possible to recognize, measure, and characterize proteins, providing essential details about their roles, interactions, and changes. Additionally, continuous advancements in spectroscopy technologies and data analysis tools are further expanding the capabilities and applications of spectroscopy in the proteomics market.

Region with largest share:

Asia-Pacific is anticipated to have largest share during the forecast period. The expansion of the proteomics industry in this area is due to the presence of pharmaceutical businesses there as well as the rising elderly population in nations like China and India. Additionally, as demand for personalized medicine rises, so does the need for drug discovery and developments in the biotechnology industry fuel market expansion in the region. The Asia-Pacific area has the largest pharmaceutical sector, and a wealth of technologically advanced medical devices that may be easily accessed by producers of proteomics-based goods.

Region with highest CAGR:

North America commanded highest CAGR throughout the domination period due to the development of structure-based drug design, expansion of omics research, desire for high-quality research tools for data reproducibility, and focus on the creation of personalized treatments. Partnerships and collaborations among significant businesses in this region are also helping to expand this industry. Furthermore, in order to accelerate the characterisation and quality monitoring of complex therapeutic proteins, Thermo Fisher Scientific Inc. and Symphogen developed a proven platform process.

Key players in the market:

Some of the key players in Proteomics Market include: Agilent Technologies, inc., Illumina, Inc., Ge Healthcare, Bio - Rad Laboratories, Inc., Bruker Corporation, Thermo fisher Scientific, Inc., Promega Corporation , F.Hoffmann-La Roche Ltd., Danaher, Merck Kgaa., Waters Corporation, Caprion Proteomics Inc., Luminex Corporation, PerkinElmer, Inc., SomaLogic Operating Co. and Olink.

Key Developments:

In February 2023, Waters Corporation acquired Wyatt Technology, which enhances the portfolio of Separation and Detection, which provides customers with an unmatched set of analytical solutions across a wide range of applications.

In October 2022, Agilent Technologies Inc. and CMP Scientific Corp. entered into a co-marketing agreement to provide an integrated capillary electrophoresis-mass spectrometry (CE-MS) solution for the life science and pharmaceutical industries.

In August 2022, Bruker Corporation introduced the new nano Elute 2 nano-LC, MetaboScape, and TASQ software to promote the study of protein-protein interaction and metaproteomics applications. These products also support fluxomics and the most recent developments in PaSER intelligent acquisition.

Products Covered:

  • Reagents & Consumables
  • Instruments
  • Services

Services & Softwares Covered:

  • Core Proteomics Services
  • Bioinformatics Services & Software

Technologies Covered:

  • Spectroscopy
  • Chromatography
  • Electrophoresis
  • Protein Microarrays
  • X-Ray Crystallography
  • Surface Plasmon Resonance
  • Protein Fractionation
  • Other Technologies

Applications Covered:

  • Clinical Diagnosis
  • Clinical Research
  • Drug Discovery
  • Other Applications

End Users Covered:

  • Laboratories
  • Academic & Research Institute
  • Hospitals
  • Pharmaceutical & Biopharmaceutical Companies
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Proteomics Market, By Product

  • 5.1 Introduction
  • 5.2 Reagents & Consumables
  • 5.3 Instruments
  • 5.4 Services

6 Global Proteomics Market, By Services & Software

  • 6.1 Introduction
  • 6.2 Core Proteomics Services
    • 6.2.1 Protein Characterization Services
    • 6.2.2 Protein Identification Services
    • 6.2.3 Protein Purification Services
    • 6.2.4 Quantitative Proteomics Services
    • 6.2.5 Protein Seqencing Services
    • 6.2.6 Protein Separation Services
    • 6.2.7 Custom Assay Services
  • 6.3 Bioinformatics Services & Software
    • 6.3.1 Bioinformatics Tools
    • 6.3.2 Bioinformatics Services
    • 6.3.3 Bioinformatics Databases

7 Global Proteomics Market, By Technology

  • 7.1 Introduction
  • 7.2 Spectroscopy
    • 7.2.1 Mass Spectroscopy
  • 72.2 Nuclear Magnetic Resonance Spectroscopy
    • 7.2.2 Circular Dichroism Spectroscopy
  • 7.3 Chromatography
    • 7.3.1 High Performance Liquid Chromatography
    • 7.3.2 Supercritical Fluid Chromatography
    • 7.3.3 Affinity Chromatography
    • 7.3.4 Ion Chromatography
  • 7.4 Electrophoresis
    • 7.4.1 Gel Electrophoresis
    • 7.4.2 Capillary Electrophoresis
  • 7.5 Protein Microarrays
    • 7.5.1 Biochips
      • 7.5.1.1 Lab-On-Chips
      • 7.5.1.2 Protein Chips
    • 7.5.2 Microarray Instruments
      • 7.5.2.1 Integrated Systems
      • 7.5.2.2 Arrayers
      • 7.5.2.3 Microarray Scanners
  • 7.6 X-Ray Crystallography
  • 7.7 Surface Plasmon Resonance
  • 7.8 Protein Fractionation
  • 7.9 Other Technologies

8 Global Proteomics Market, By Application

  • 8.1 Introduction
  • 8.2 Clinical Diagnosis
    • 8.2.1 Infectious Diseases
    • 8.2.2 Cancer
    • 8.2.3 Diabetes
    • 8.2.4 Autoimmune Diseases
    • 8.2.5 Neurological Disorders
    • 8.2.6 Cardiovascular Diseases
    • 8.2.7 Other Clinical Diagnostic Application
  • 8.3 Clinical Research
  • 8.4 Drug Discovery
    • 8.4.1 Target Discovery
    • 8.4.2 Lead Optimization
    • 8.4.3 Lead Identification
    • 8.4.4 Preclinical Studies
  • 8.5 Other Applications

9 Global Proteomics Market, By End User

  • 9.1 Introduction
  • 9.2 Laboratories
  • 9.3 Academic & Research Institute
  • 9.4 Hospitals
  • 9.5 Pharmaceutical & Biopharmaceutical Companies
  • 9.6 Other End Users

10 Global Proteomics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Agilent Technologies, inc.
  • 12.2 Illumina, Inc.
  • 12.3 Ge Healthcare
  • 12.4 Bio - Rad Laboratories, Inc.
  • 12.5 Bruker Corporation
  • 12.6 Thermo fisher Scientific, Inc.
  • 12.7 Promega Corporation
  • 12.8 F. Hoffmann-La Roche Ltd.
  • 12.9 Danaher
  • 12.10 Merck Kgaa.
  • 12.11 Waters Corporation
  • 12.12 Caprion Proteomics Inc.
  • 12.13 Luminex Corporation
  • 12.14 PerkinElmer, Inc.
  • 12.15 SomaLogic Operating Co.
  • 12.16 Olink

List of Tables

  • Table 1 Global Proteomics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Proteomics Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Proteomics Market Outlook, By Reagents & Consumables (2021-2030) ($MN)
  • Table 4 Global Proteomics Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global Proteomics Market Outlook, By Services (2021-2030) ($MN)
  • Table 6 Global Proteomics Market Outlook, By Services & Software (2021-2030) ($MN)
  • Table 7 Global Proteomics Market Outlook, By Core Proteomics Services (2021-2030) ($MN)
  • Table 8 Global Proteomics Market Outlook, By Protein Characterization Services (2021-2030) ($MN)
  • Table 9 Global Proteomics Market Outlook, By Protein Identification Services (2021-2030) ($MN)
  • Table 10 Global Proteomics Market Outlook, By Protein Purification Services (2021-2030) ($MN)
  • Table 11 Global Proteomics Market Outlook, By Quantitative Proteomics Services (2021-2030) ($MN)
  • Table 12 Global Proteomics Market Outlook, By Protein Seqencing Services (2021-2030) ($MN)
  • Table 13 Global Proteomics Market Outlook, By Protein Separation Services (2021-2030) ($MN)
  • Table 14 Global Proteomics Market Outlook, By Custom Assay Services (2021-2030) ($MN)
  • Table 15 Global Proteomics Market Outlook, By Bioinformatics Services & Software (2021-2030) ($MN)
  • Table 16 Global Proteomics Market Outlook, By Bioinformatics Tools (2021-2030) ($MN)
  • Table 17 Global Proteomics Market Outlook, By Bioinformatics Services (2021-2030) ($MN)
  • Table 18 Global Proteomics Market Outlook, By Bioinformatics Databases (2021-2030) ($MN)
  • Table 19 Global Proteomics Market Outlook, By Technology (2021-2030) ($MN)
  • Table 20 Global Proteomics Market Outlook, By Spectroscopy (2021-2030) ($MN)
  • Table 21 Global Proteomics Market Outlook, By Mass Spectroscopy (2021-2030) ($MN)
  • Table 22 Global Proteomics Market Outlook, By Nuclear Magnetic Resonance Spectroscopy (2021-2030) ($MN)
  • Table 23 Global Proteomics Market Outlook, By Circular Dichroism Spectroscopy (2021-2030) ($MN)
  • Table 24 Global Proteomics Market Outlook, By Chromatography (2021-2030) ($MN)
  • Table 25 Global Proteomics Market Outlook, By High Performance Liquid Chromatography (2021-2030) ($MN)
  • Table 26 Global Proteomics Market Outlook, By Supercritical Fluid Chromatography (2021-2030) ($MN)
  • Table 27 Global Proteomics Market Outlook, By Affinity Chromatography (2021-2030) ($MN)
  • Table 28 Global Proteomics Market Outlook, By Ion Chromatography (2021-2030) ($MN)
  • Table 29 Global Proteomics Market Outlook, By Electrophoresis (2021-2030) ($MN)
  • Table 30 Global Proteomics Market Outlook, By Gel Electrophoresis (2021-2030) ($MN)
  • Table 31 Global Proteomics Market Outlook, By Capillary Electrophoresis (2021-2030) ($MN)
  • Table 32 Global Proteomics Market Outlook, By Protein Microarrays (2021-2030) ($MN)
  • Table 33 Global Proteomics Market Outlook, By Biochips (2021-2030) ($MN)
  • Table 34 Global Proteomics Market Outlook, By Microarray Instruments (2021-2030) ($MN)
  • Table 35 Global Proteomics Market Outlook, By X-Ray Crystallography (2021-2030) ($MN)
  • Table 36 Global Proteomics Market Outlook, By Surface Plasmon Resonance (2021-2030) ($MN)
  • Table 37 Global Proteomics Market Outlook, By Protein Fractionation (2021-2030) ($MN)
  • Table 38 Global Proteomics Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 39 Global Proteomics Market Outlook, By Application (2021-2030) ($MN)
  • Table 40 Global Proteomics Market Outlook, By Clinical Diagnosis (2021-2030) ($MN)
  • Table 41 Global Proteomics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 42 Global Proteomics Market Outlook, By Cancer (2021-2030) ($MN)
  • Table 43 Global Proteomics Market Outlook, By Diabetes (2021-2030) ($MN)
  • Table 44 Global Proteomics Market Outlook, By Autoimmune Diseases (2021-2030) ($MN)
  • Table 45 Global Proteomics Market Outlook, By Neurological Disorders (2021-2030) ($MN)
  • Table 46 Global Proteomics Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
  • Table 47 Global Proteomics Market Outlook, By Other Clinical Diagnostic Application (2021-2030) ($MN)
  • Table 48 Global Proteomics Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 49 Global Proteomics Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 50 Global Proteomics Market Outlook, By Target Discovery (2021-2030) ($MN)
  • Table 51 Global Proteomics Market Outlook, By Lead Optimization (2021-2030) ($MN)
  • Table 52 Global Proteomics Market Outlook, By Lead Identification (2021-2030) ($MN)
  • Table 53 Global Proteomics Market Outlook, By Preclinical Studies (2021-2030) ($MN)
  • Table 54 Global Proteomics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 55 Global Proteomics Market Outlook, By End User (2021-2030) ($MN)
  • Table 56 Global Proteomics Market Outlook, By Laboratories (2021-2030) ($MN)
  • Table 57 Global Proteomics Market Outlook, By Academic & Research Institute (2021-2030) ($MN)
  • Table 58 Global Proteomics Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 59 Global Proteomics Market Outlook, By Pharmaceutical & Biopharmaceutical Companies (2021-2030) ($MN)
  • Table 60 Global Proteomics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.